Cargando…
Prognosis in Pediatric Myasthenia Gravis
Investigators from Oxford John Radcliff Hospital and Great Ormond Street Hospital for Children performed a retrospective study of myasthenia patients diagnosed before the age of 16 years.
Autor principal: | Krueger, Jena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pediatric Neurology Briefs Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759326/ https://www.ncbi.nlm.nih.gov/pubmed/33376293 http://dx.doi.org/10.15844/pedneurbriefs-34-24 |
Ejemplares similares
-
Eculizumab versus rituximab in generalised myasthenia gravis
por: Nelke, Christopher, et al.
Publicado: (2022) -
Myasthenia gravis in clinical practice
por: Estephan, Eduardo de Paula, et al.
Publicado: (2022) -
Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan
por: Imai, Tomihiro, et al.
Publicado: (2018) -
Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs
por: Cetin, Hakan, et al.
Publicado: (2020) -
The association between anti‐acetylcholine receptor antibody level and clinical improvement in myasthenia gravis
por: Marcuse, Florit, et al.
Publicado: (2022)